SARS-CoV-2 variants circulating in West and Central Africa between 2020 and 2022: A retrospective study
Guilbaud Romane, Almoustapha Issiaka Maiga, Abdoul–Salam Ouédraogo, Yacouba Sawadogo et autres
0 citationsJournal of Infection and Public Health
Agence Nationale de Recherches sur le Sida et les Hépatites Virales
Paris · FR · facility
621Publications signalées
76034Citations signalées
12Thèmes principaux
Principaux domaines
Hepatitis C virus researchHIV Research and TreatmentHIV/AIDS drug development and treatmentHIV/AIDS Research and InterventionsHepatitis B Virus StudiesLiver Disease Diagnosis and TreatmentHIV-related health complications and treatmentsSARS-CoV-2 and COVID-19 ResearchHIV, Drug Use, Sexual RiskHepatitis Viruses Studies and EpidemiologyLiver Disease and TransplantationViral Infections and Outbreaks Research
Évolution annuelle
Publications récentes
Evolution of Untreated Anal High-Grade Squamous Intraepithelial Lesions in High-Risk Men: A Prospective 5-Year Clinical Follow-up in the ANRS-EP57-APACHES Study
Isabelle Etienney, Deependra Singh, E. Ressiot, Jean‐Michel Didelot et autres
0 citationsClinical Infectious Diseases
Importation risk and preparedness priorities across Africa in the 2026 Bundibugyo Ebola outbreak
Federico Fanelli, Francesco Parino, Maria Amalia Pelle, Boxuan Wang et autres
0 citationsmedRxiv
Self-Supervised Feature Extraction for Domain-Specific Anomaly Detection with Normalizing Flows
CORNIS SAS, Thibault Richard, Université d’Orléans, Bruno Galerne et autres
0 citationse-Journal of Nondestructive Testing
Prevalence of Delta hepatitis virus in Antananarivo, Madagascar
Lucia Mélanie Ravaoharisoa, Andry Toky Rakotoarivo, Rina Rakotozafindrabe, Valérian Delagarde et autres
0 citationsInfectious Diseases Now
Comparison of four frailty scores to predict adverse health events and mortality in people living with HIV aged 70 years and more ( ANRS EP 66 SEPTAVIH study)
Clotilde Allavena, Diane Abulizi, Hubert Blain, Valérie Andriantsoanirina et autres
0 citationsHIV Medicine
Five-year immunogenicity and safety follow-up of the PREVAC randomized Trial of Vaccines for Zaire Ebola Virus Disease
Abdoul Habib Béavogui, Seydou Doumbia, Mark Kieh, Bailah Leigh et autres
0 citationsmedRxiv
CD40.HIVEnv, an antibody mediated vaccine, induces long-term and recall immunogenicity in non-HIV-1 infected volunteers
Yves Levy, Christiane Moog, Aurélie Wiedemann, Odile Launay et autres
0 citationsScientific Reports
Cross-reactive Bundibugyo antibody responses after licensed Ebola vaccines
Edouard Lhomme, Aurélie Wiedemann, Ahidjo Ayouba, Safaa Ben-Farhat et autres
2 citationsmedRxiv
CONVICTION-CHIK study on the effect of convalescent plasma for mother-to-child Chikungunya infection: protocol for a multicentre, open label, single-arm, phase II trial
Silvia Iacobelli, Syria Laperche, A. Pasquet, Kassim Papa et autres
0 citationsBMC Pregnancy and Childbirth
Diminution de la prévalence de l'hépatite B chez les femmes enceintes, après l'introduction de la vaccination à la naissance au nord du Cameroun.
J. Birguel, M. Dourwe, J. Adoukara, J. Abdal et autres
0 citationsMédecine et Maladies Infectieuses Formation
Short-cycle 4-days-per-week maintenance two-drug therapy in people living with HIV (ANRS-177 DUETTO): a randomised, open-label, multicentre, non-inferiority trial
Roland Landman, Roland Landman, L. Assoumou, Sidonie Lambert-Niclot et autres
0 citationsThe Lancet HIV
BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.